Tiziani, Stefano

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A.-N. A., et al. (2018) · Nature Medicine

Cancer, Hypoxia, and MetabolismMitochondrial Function and Pathology

Cited by 928

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

Triplett, T. A., Garrison, K. C., Marshall, N., Donkor, M., Blazeck, J., Lamb, C., Qerqez, A., Dekker, J. D., Tanno, Y., Lu, W.-C., et al. (2018) · Nature Biotechnology

Cancer Immunotherapy and BiomarkersTryptophan and brain disorders

Cited by 321

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes

Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S. M., Lodi, A., Sweeney, S. R., Ma, H., et al. (2016) · Oncotarget

Acute Myeloid Leukemia ResearchCancer, Hypoxia, and Metabolism

Cited by 185

Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library

Tiziani, S., Kang, Y., Choi, J. S., Roberts, W., & Paternostro, G. (2011) · Nature Communications

Metabolomics and Mass Spectrometry StudiesCancer, Hypoxia, and Metabolism

Cited by 60